Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / SPONSORED ADS
-
Total 13F shares
-
81,771
-
Share change
-
-155,423
-
Total reported value
-
$3,219,883
-
Price per share
-
$39.38
-
Number of holders
-
11
-
Value change
-
-$2,881,944
-
Number of buys
-
9
-
Number of sells
-
5
Institutional Holders of ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS (AAPG) as of Q2 2025
As of 30 Jun 2025,
ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS (AAPG) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
81,771 shares.
The largest 10 holders included
Point72 (DIFC) Ltd, NEOS Investment Management LLC, TEMA ETFS LLC, HSBC HOLDINGS PLC, UBS Group AG, Chevy Chase Trust Holdings, LLC, XY Capital Ltd, MORGAN STANLEY, JPMORGAN CHASE & CO, and Bell Investment Advisors, Inc.
This page lists
11
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.